Glen Eagle Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-48	Closed	-$4.09K	–	664
2017 Q3	$4.09K	Hold	48	–	–	﹤0.01%	540
2017 Q2	$3.64K	Hold	48	–	–	﹤0.01%	504
2017 Q1	$3.18K	Buy	+48	New	+$3.18K	﹤0.01%	491
2016 Q4	–	Hold	0	–	–	–	539